TuHURA Biosciences, Inc.
HURA
$2.01
-$0.11-5.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.54M | 8.26M | 7.98M | 6.92M | 5.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.42M | 29.44M | 28.51M | 25.37M | 22.37M |
| Operating Income | -31.42M | -29.44M | -28.51M | -25.37M | -22.37M |
| Income Before Tax | -30.62M | -30.92M | -30.05M | -29.29M | -27.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.62 | -30.92 | -30.05 | -29.29 | -27.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.62M | -30.92M | -30.05M | -29.29M | -27.76M |
| EBIT | -31.42M | -29.44M | -28.51M | -25.37M | -22.37M |
| EBITDA | -31.32M | -29.36M | -28.44M | -25.30M | -22.30M |
| EPS Basic | -0.54 | -0.61 | -0.64 | -0.66 | -1.06 |
| Normalized Basic EPS | -0.36 | -0.36 | -0.37 | -0.36 | -0.56 |
| EPS Diluted | -0.54 | -0.61 | -0.64 | -0.66 | -1.06 |
| Normalized Diluted EPS | -0.36 | -0.36 | -0.37 | -0.36 | -0.56 |
| Average Basic Shares Outstanding | 227.64M | 208.23M | 191.63M | 176.75M | 138.26M |
| Average Diluted Shares Outstanding | 227.64M | 208.23M | 191.63M | 176.75M | 138.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.03% | -0.03% | -0.03% | -0.02% | -0.02% |